GeoVax Labs, Inc. New

GOVXNASDAQ • USD
ThemeBiotech - Drug Development›Infectious Disease & Vaccines
1.32 USD
↗ 0.01 (0.76%)AT CLOSE (11:59 AM EDT)
1.29
↘ 0.03 (2.20%)
POST MARKET (AS OF 08:00 PM EDT)
Post Market
AS OF 08:00 PM EDT
1.29
↘ 0.03 (2.20%)
🔴Market: CLOSED

GeoVax Labs, Inc. New (GOVX) trades at $1.32 per share. Our models show a "Strong Sell" technical signal alongside a "Neutral" fundamental rating. Notable factors include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. Valuation-wise, the stock is priced at a premium — multiples like P/E and EV/EBITDA sit above sector averages.

Technical & fundamental data as of Jun 26, 2026.

Open?$1.25
High?$1.37
Low?$1.25
Prev. Close?$1.31
Volume?211.3K
Avg. Volume?10.2M
VWAP?$1.33
Rel. Volume?0.02x
Bid / Ask
Bid?$1.28 × 700
Ask?$1.30 × 500
Spread?$0.02
Midpoint?$1.29
Valuation & Ratios
Market Cap?6.9M
Shares Out?5.2M
Float?43.1M
Float %?99.4%
P/E Ratio?N/A
P/B Ratio?13.93
EPS?-$4.10
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Geovax Labs Inc is a clinical-stage biotechnology company developing human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms. The company is focused on the advancement of GEO-MVA, a Modified Vaccinia Ankara (MVA) vaccine candidate for mpox, smallpox, and other poxviruses. Its flagship clinical program in oncology is Gedeptin, a novel oncolytic solid tumor gene-directed therapy, which recently completed a multicenter Phase 1/2 clinical trial for head and neck cancers. The company is also developing GEO-CM04S1, a next-generation multi-antigen COVID-19 vaccine, which is currently being evaluated in two Phase 2 clinical trials.
Themes
Biotech - Drug Development›Infectious Disease & VaccinesHealthcare - Oncology›Immunotherapy & Immuno-Oncology
Employees
19
Market Cap
6.8M
Industry
PHARMACEUTICAL PREPARATIONS
Website
www.geovax.com
Listed
1995-02-01
Address
1955 LAKE PARK DRIVE
SMYRNA, GA
Phone: 678-384-7220
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-3/3)
Medium-Term (Wave)?▼ Bearish(-2/3)
Short-Term (Ripple)?▲ Bullish(+2/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →
Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
0
Momentum?
77
Short Sent.?
100
Piotroski F-Score?0/9Weak
Altman Z-Score?-95.06Distress
Confidence?40%Low
Full Fundamental Analysis →
Short InterestLow
Short % of Float?0.63%Low
Short Interest?271.8K
Days to Cover?1.0
Free Float43.1M
Avg Daily Volume1.2M
Settlement Date2026-06-15
Financial Health
Current Ratio?1.06Adequate
Quick Ratio?1.06Adequate
Cash Ratio?0.55Adequate
Debt/Equity?0.00Low
ValuationRICHLY VALUEDvs 1 peers + S&P 500
Score
50/100
P/E?
N/A▾
P/B?
Peers
100
S&P
13
13.93HIGH▾
P/S?
Peers
100
S&P
13
8.07HIGH▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-0.3CHEAP▾
EV/Sales?
Peers
100
S&P
23
6.58HIGH▾
Returns & Efficiency
ROE?
S&P
3
-4,327.7%WEAK▾
ROA?
S&P
3
-716.5%WEAK▾
Cash Flow & Enterprise
FCF?$-19056728
Enterprise Value?$5.6M
Fundamentals ratios updated end of day
MarketsMoversWatchlist